Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226
about
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialLactic acidosis in a patient with multiple myeloma.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myelomaAkt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2.Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma.Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation.JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells.Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts.B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorDifferential Effects of Hormones on Cellular Metabolism in Keratoconus In Vitro.Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsMultiple myeloma: increasing evidence for a multistep transformation process.Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation.
P2860
Q28075927-AE1C0CB6-454B-4834-B3A1-66ED1ABA9B6AQ33608140-E3F6561D-CD28-4041-837A-C45B75AFC4A8Q33890792-711ED456-F10D-4D8F-9385-BA08DAD972D8Q33994341-75EA7073-5ABE-44D6-B794-FDEEBFD0BD07Q34241184-CFB36402-2124-487A-A812-A3F019D83796Q34890267-D53ED451-11B1-41AA-A567-D9121EB86BEBQ35120698-829084E2-CCD5-401B-BC76-16DE0710305BQ35900943-1F68A2AF-35FC-497C-A0FF-D71196A44F4FQ36059640-B521F819-15A8-4E1E-AF53-7B2A77A30693Q36924505-45A6BB88-8C7E-43A0-B9D6-92B0378F279AQ37215171-F7113B2B-5B50-4393-B797-FC031680E7E6Q37648847-AB4A9D06-1F24-45D1-809D-9C934BC925DBQ40328451-196EB378-AA93-42B8-804A-C743B01FAF01Q41670812-3DAE7C05-DC24-49B2-B99B-C78431753612Q41770950-81AAA06B-FDC4-46F2-9BE5-D186817D373BQ43979784-32875EE5-EC2B-476A-A06C-2819273BD653
P2860
Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@ast
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en-gb
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@nl
type
label
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@ast
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en-gb
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@nl
prefLabel
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@ast
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en-gb
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@nl
P2093
P921
P3181
P1476
Insulin and IGF-1 increase mit ...... e myeloma cell line, RPMI 8226
@en
P2093
P304
P3181
P407
P577
1993-08-01T00:00:00Z